Cited by 26Down syndrome and intellectual disability researchGenetics and Neurodevelopmental DisordersAlzheimer's disease research and treatments

Integrative multi-omic analysis reveals conserved cell-projection deficits in human Down syndrome brains

Open access
Rastogi, Mohit, Bartolucci, Martina, Nanni, Marina, Aloisio, Michelangelo, Vozzi, Diego, Petretto, Andrea, Contestabile, Andrea, Cancedda, Laura·2024·Neuron

Abstract

Down syndrome (DS) is the most common genetic cause of cognitive disability. However, it is largely unclear how triplication of a small gene subset may impinge on diverse aspects of DS brain physiopathology. Here, we took a multi-omic approach and simultaneously analyzed by RNA-seq and proteomics the expression signatures of two diverse regions of human postmortem DS brains. We found that the overexpression of triplicated genes triggered global expression dysregulation, differentially affecting transcripts, miRNAs, and proteins involved in both known and novel biological candidate pathways. Among the latter, we observed an alteration in RNA splicing, specifically modulating the expression of genes involved in cytoskeleton and axonal dynamics in DS brains. Accordingly, we found an alteration in axonal polarization in neurons from DS human iPSCs and mice. Thus, our study provides an integrated multilayer expression database capable of identifying new potential targets to aid in designing future clinical interventions for DS.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuron.2024.05.002

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • These data are consistent with a previous report comparing bulk proteomics and bulk RNAseq in brain samples from young individuals with DS compared with euploid-matched controls, which also reported a discordance between transcript and protein levels.

    “These data are consistent with a previous report comparing bulk proteomics and bulk RNAseq in brain samples from young individuals with DS compared with euploid-matched controls, which also reported a discordance between transcript and protein levels [56].”

    From Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease (2025) · cites this paper as [56]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured
  • Homeostatic processes can regulate the abundance of proteins, such that a raised level of a transcript does not always increase the abundance of the corresponding protein.

    “Homeostatic processes can regulate the abundance of proteins, such that the raised level of a transcript does not always increase the abundance of the corresponding protein [8, 56, 59].”

    From Apolipoprotein E abundance is elevated in the brains of individuals with Down syndrome–Alzheimer’s disease (2025) · cites this paper as [56]

    The Results (page unavailable) show that mRNA and corresponding protein changes often differ in direction, supporting the point that a raised transcript level need not mean more protein. The Discussion (page unavailable) suggests posttranscriptional or posttranslational regulation, but does not establish that the processes responsible are homeostatic. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Part of this paper’s reference list could not be split into single entries.

Flagged first, then by citations

Research works printed but not linked: 117

  1. [2]2. Vicari, S. ∙ Bellucci, S. ∙ Carlesimo, G.A. Implicit and explicit memory: a functional dissociation in persons with Down syndrome Neuropsychologia. 2000; 38:240-251 Crossref Scopus (112) PubMed Google Scholar
  2. [3]3. Roizen, N.J. ∙ Patterson, D. Down’s syndrome Lancet. 2003; 361:1281-1289 Full Text Full Text (PDF) Scopus (958) PubMed Google Scholar
  3. [4]4. Sherman, S.L. ∙ Allen, E.G. ∙ Bean, L.H. ... Epidemiology of Down syndrome Ment. Retard. Dev. Disabil. Res. Rev. 2007; 13:221-227 Crossref Scopus (349) PubMed Google Scholar
  4. [5]5. Contestabile, A. ∙ Benfenati, F. ∙ Gasparini, L. Communication breaks-Down: from neurodevelopment defects to cognitive disabilities in Down syndrome Prog. Neurobiol. 2010; 91:1-22 Crossref Scopus (0) PubMed Google Scholar
  5. [6]6. Rachidi, M. ∙ Lopes, C. Mental retardation and human Chromosome 21 gene overdosage: from functional genomics and molecular mechanisms towards prevention and treatment of the neuropathogenesis of Down syndrome Clelland, J.D. (Editor) Genomics, Proteomics, and the Nervous System Springer, 2011; 21-86 Crossref Google Scholar
  6. [7]7. Kazemi, M. ∙ Salehi, M. ∙ Kheirollahi, M. Down syndrome: current status, challenges and future perspectives Int. J. Mol. Cell. Med. 2016; 5:125-133 PubMed Google Scholar
  7. [8]8. Mégarbané, A. ∙ Ravel, A. ∙ Mircher, C. ... The 50th anniversary of the discovery of trisomy 21: The past, present, and future of research and treatment of Down syndrome Genet. Med. 2009; 11:611-616 Full Text Full Text (PDF) Scopus (176) PubMed Google Scholar
  8. [9]9. Letourneau, A. ∙ Santoni, F.A. ∙ Bonilla, X. ... Domains of genome-wide gene expression dysregulation in Down’s syndrome Nature. 2014; 508:345-350 Crossref Scopus (227) PubMed Google Scholar
  9. [10]10. Wiseman, F.K. ∙ Alford, K.A. ∙ Tybulewicz, V.L.J. ... Down syndrome--recent progress and future prospects Hum. Mol. Genet. 2009; 18:R75-R83 Crossref Scopus (194) PubMed Google Scholar
  10. [11]11. Herault, Y. ∙ Delabar, J.M. ∙ Fisher, E.M.C. ... Rodent models in Down syndrome research: impact and future opportunities Dis. Model. Mech. 2017; 10:1165-1186 Crossref Scopus (129) PubMed Google Scholar
  11. [12]12. Vacca, R.A. ∙ Bawari, S. ∙ Valenti, D. ... Down syndrome: neurobiological alterations and therapeutic targets Neurosci. Biobehav. Rev. 2019; 98:234-255 Crossref Scopus (62) PubMed Google Scholar
  12. [13]13. Rueda, N. ∙ Flórez, J. ∙ Dierssen, M. ... Translational validity and implications of pharmacotherapies in preclinical models of Down syndrome Prog. Brain Res. 2020; 251:245-268 Crossref Scopus (20) PubMed Google Scholar
  13. [14]14. Sommer, C.A. ∙ Pavarino-Bertelli, E.C. ∙ Goloni-Bertollo, E.M. ... Identification of dysregulated genes in lymphocytes from children with Down syndrome Genome. 2008; 51:19-29 Crossref Scopus (37) PubMed Google Scholar
  14. [15]15. Guedj, F. ∙ Pennings, J.L.A. ∙ Massingham, L.J. ... An integrated human/murine transcriptome and pathway approach to identify prenatal treatments for Down syndrome Sci. Rep. 2016; 6, 32353 Crossref Scopus (42) PubMed Google Scholar
  15. [16]16. Liu, Y. ∙ Borel, C. ∙ Li, L. ... Systematic proteome and proteostasis profiling in human trisomy 21 fibroblast cells Nat. Commun. 2017; 8, 1212 Crossref Scopus (84) Google Scholar
  16. [17]17. Liu, H. ∙ Wang, H. ∙ Zhu, H. ... Preliminary study of protein changes in trisomy 21 fetus by proteomics analysis in amniocyte Prenat. Diagn. 2018; 38:435-444 Crossref Scopus (3) PubMed Google Scholar
  17. [18]18. Stamoulis, G. ∙ Garieri, M. ∙ Makrythanasis, P. ... Single cell transcriptome in aneuploidies reveals mechanisms of gene dosage imbalance Nat. Commun. 2019; 10, 4495 Crossref Scopus (26) PubMed Google Scholar
  18. [19]19. Waugh, K.A. ∙ Araya, P. ∙ Pandey, A. ... Mass cytometry reveals global immune remodeling with multi-lineage hypersensitivity to Type I interferon in Down syndrome Cell Rep. 2019; 29:1893-1908.e4 Full Text Full Text (PDF) Scopus (68) PubMed Google Scholar
  19. [20]20. Lanzillotta, C. ∙ Greco, V. ∙ Valentini, D. ... Proteomics study of peripheral blood mononuclear cells in Down syndrome children Antioxidants (Basel). 2020; 9, 1112 Crossref Scopus (5) Google Scholar
  20. [23]23. Sobol, M. ∙ Klar, J. ∙ Laan, L. ... Transcriptome and proteome profiling of neural induced pluripotent stem cells from individuals with Down syndrome disclose dynamic dysregulations of key pathways and cellular functions Mol. Neurobiol. 2019; 56:7113-7127 Crossref Scopus (40) PubMed Google Scholar
  21. [29]29. Liu, Y. ∙ Aebersold, R. The interdependence of transcript and protein abundance: new data–new complexities Mol. Syst. Biol. 2016; 12, 856 Crossref Scopus (21) Google Scholar
  22. [31]31. Pan, Q. ∙ Shai, O. ∙ Lee, L.J. ... Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing Nat. Genet. 2008; 40:1413-1415 Crossref Scopus (2846) PubMed Google Scholar
  23. [32]32. Wang, E.T. ∙ Sandberg, R. ∙ Luo, S. ... Alternative isoform regulation in human tissue transcriptomes Nature. 2008; 456:470-476 Crossref Scopus (3908) PubMed Google Scholar
  24. [33]33. Darmanis, S. ∙ Sloan, S.A. ∙ Zhang, Y. ... A survey of human brain transcriptome diversity at the single cell level Proc. Natl. Acad. Sci. USA. 2015; 112:7285-7290 Crossref Scopus (895) PubMed Google Scholar
  25. [34]34. Lake, B.B. ∙ Ai, R. ∙ Kaeser, G.E. ... Neuronal subtypes and diversity revealed by single-nucleus RNA sequencing of the human brain Science. 2016; 352:1586-1590 Crossref Scopus (594) PubMed Google Scholar
  26. [35]35. Lake, B.B. ∙ Chen, S. ∙ Sos, B.C. ... Integrative single-cell analysis of transcriptional and epigenetic states in the human adult brain Nat. Biotechnol. 2018; 36:70-80 Crossref Scopus (562) PubMed Google Scholar
  27. [37]37. Macosko, E.Z. ∙ Basu, A. ∙ Satija, R. ... Highly parallel genome-wide expression profiling of individual cells using nanoliter droplets Cell. 2015; 161:1202-1214 Full Text Full Text (PDF) Scopus (4617) PubMed Google Scholar
  28. [38]38. Usoskin, D. ∙ Furlan, A. ∙ Islam, S. ... Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing Nat. Neurosci. 2015; 18:145-153 Crossref Scopus (1423) PubMed Google Scholar
  29. [39]39. Zeisel, A. ∙ Muñoz-Manchado, A.B. ∙ Codeluppi, S. ... Brain structure. Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq Science. 2015; 347:1138-1142 Crossref Scopus (2104) PubMed Google Scholar
  30. [40]40. Tasic, B. ∙ Yao, Z. ∙ Graybuck, L.T. ... Shared and distinct transcriptomic cell types across neocortical areas Nature. 2018; 563:72-78 Crossref Scopus (909) PubMed Google Scholar
  31. [42]42. Créau, N. Molecular and cellular alterations in Down syndrome: toward the identification of targets for therapeutics Neural Plast. 2012; 2012, 171639 Crossref Scopus (25) PubMed Google Scholar
  32. [43]43. Zhang, Z. ∙ Stolrow, H.G. ∙ Christensen, B.C. ... Down syndrome altered cell composition in blood, brain, and buccal swab samples profiled by DNA-methylation-based cell-type deconvolution Cells. 2023; 12, 1168 Crossref Scopus (5) Google Scholar
  33. [44]44. Contestabile, A. ∙ Magara, S. ∙ Cancedda, L. The GABAergic hypothesis for cognitive disabilities in Down syndrome Front. Cell. Neurosci. 2017; 11, 54 Crossref Scopus (91) PubMed Google Scholar
  34. [46]46. Weaver, C.L. ∙ Espinoza, M. ∙ Kress, Y. ... Conformational change as one of the earliest alterations of tau in Alzheimer’s disease Neurobiol. Aging. 2000; 21:719-727 Crossref Scopus (275) PubMed Google Scholar
  35. [47]47. Koss, D.J. ∙ Jones, G. ∙ Cranston, A. ... Soluble pre-fibrillar tau and β-amyloid species emerge in early human Alzheimer’s disease and track disease progression and cognitive decline Acta Neuropathol. 2016; 132:875-895 Crossref Scopus (92) PubMed Google Scholar
  36. [48]48. Oddo, S. ∙ Caccamo, A. ∙ Shepherd, J.D. ... Triple-transgenic model of Alzheimer’s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction Neuron. 2003; 39:409-421 Full Text Full Text (PDF) Scopus (3451) PubMed Google Scholar
  37. [49]49. Johnson, E.C.B. ∙ Carter, E.K. ∙ Dammer, E.B. ... Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA level Nat. Neurosci. 2022; 25:213-225 Crossref Scopus (166) PubMed Google Scholar
  38. [50]50. Lewis, B.P. ∙ Burge, C.B. ∙ Bartel, D.P. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets Cell. 2005; 120:15-20 Full Text Full Text (PDF) Scopus (10308) PubMed Google Scholar
  39. [51]51. Agarwal, V. ∙ Bell, G.W. ∙ Nam, J.-W. ... Predicting effective microRNA target sites in mammalian mRNAs eLife. 2015; 4, e05005 Crossref Scopus (5300) PubMed Google Scholar
  40. [52]52. Ule, J. ∙ Blencowe, B.J. Alternative splicing regulatory networks: functions, mechanisms, and evolution Mol. Cell. 2019; 76:329-345 Full Text Full Text (PDF) Scopus (399) PubMed Google Scholar
  41. [53]53. Tapial, J. ∙ Ha, K.C.H. ∙ Sterne-Weiler, T. ... An atlas of alternative splicing profiles and functional associations reveals new regulatory programs and genes that simultaneously express multiple major isoforms Genome Res. 2017; 27:1759-1768 Crossref Scopus (239) PubMed Google Scholar
  42. [54]54. Schafer, S. ∙ Miao, K. ∙ Benson, C.C. ... Alternative splicing signatures in RNA-seq data: percent spliced in (PSI) Curr. Protoc. Hum. Genet. 2015; 87:11.16.1-11.16.14 Crossref Scopus (97) PubMed Google Scholar
  43. [56]56. Raj, B. ∙ Blencowe, B.J. Alternative splicing in the mammalian nervous system: recent insights into mechanisms and functional roles Neuron. 2015; 87:14-27 Full Text Full Text (PDF) Scopus (325) PubMed Google Scholar
  44. [57]57. Capponi, S. ∙ Stöffler, N. ∙ Irimia, M. ... Neuronal-specific microexon splicing of TAF1 mRNA is directly regulated by SRRM4/nSR100 RNA Biol. 2020; 17:62-74 Crossref Scopus (14) PubMed Google Scholar
  45. [58]58. Gonatopoulos-Pournatzis, T. ∙ Niibori, R. ∙ Salter, E.W. ... Autism-misregulated eIF4G microexons control synaptic translation and higher order cognitive functions Mol. Cell. 2020; 77:1176-1192.e16 Full Text Full Text (PDF) Scopus (64) PubMed Google Scholar
  46. [59]59. Lin, L. ∙ Zhang, M. ∙ Stoilov, P. ... Developmental attenuation of neuronal apoptosis by neural-specific splicing of Bak1 microexon Neuron. 2020; 107:1180-1196.e8 Full Text Full Text (PDF) Scopus (42) PubMed Google Scholar
  47. [60]60. Monteuuis, G. ∙ Wong, J.J.L. ∙ Bailey, C.G. ... The changing paradigm of intron retention: regulation, ramifications and recipes Nucleic Acids Res. 2019; 47:11497-11513 Crossref Scopus (94) PubMed Google Scholar
  48. [62]62. Gerstberger, S. ∙ Hafner, M. ∙ Tuschl, T. A census of human RNA-binding proteins Nat. Rev. Genet. 2014; 15:829-845 Crossref Scopus (1360) PubMed Google Scholar
  49. [63]63. Duchon, A. ∙ Raveau, M. ∙ Chevalier, C. ... Identification of the translocation breakpoints in the Ts65Dn and Ts1Cje mouse lines: relevance for modeling Down syndrome Mamm. Genome. 2011; 22:674-684 Crossref Scopus (167) PubMed Google Scholar
  50. [64]64. Weick, J.P. ∙ Held, D.L. ∙ Bonadurer, G.F. ... Deficits in human trisomy 21 iPSCs and neurons Proc. Natl. Acad. Sci. USA. 2013; 110:9962-9967 Crossref Scopus (151) PubMed Google Scholar
  51. [65]65. Cheng, P.L. ∙ Poo, M.M. Early events in axon/dendrite polarization Annu. Rev. Neurosci. 2012; 35:181-201 Crossref Scopus (84) PubMed Google Scholar
  52. [67]67. Yu, T. ∙ Li, Z. ∙ Jia, Z. ... A mouse model of Down syndrome trisomic for all human chromosome 21 syntenic regions Hum. Mol. Genet. 2010; 19:2780-2791 Crossref Scopus (180) PubMed Google Scholar
  53. [68]68. Di Domenico, F. ∙ Coccia, R. ∙ Cocciolo, A. ... Impairment of proteostasis network in Down syndrome prior to the development of Alzheimer’s disease neuropathology: redox proteomics analysis of human brain Biochim. Biophys. Acta. 2013; 1832:1249-1259 Crossref Scopus (106) PubMed Google Scholar
  54. [69]69. Pelechano, V. ∙ Wei, W. ∙ Steinmetz, L.M. Extensive transcriptional heterogeneity revealed by isoform profiling Nature. 2013; 497:127-131 Crossref Scopus (320) PubMed Google Scholar
  55. [70]70. Melé, M. ∙ Ferreira, P.G. ∙ Reverter, F. ... Human genomics. The human transcriptome across tissues and individuals Science. 2015; 348:660-665 Crossref Scopus (888) PubMed Google Scholar
  56. [72]72. Goeldner, C. ∙ Kishnani, P.S. ∙ Skotko, B.G. ... A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome J. Neurodev. Disord. 2022; 14, 10 Crossref Scopus (16) PubMed Google Scholar
  57. [74]74. Powers, R.K. ∙ Culp-Hill, R. ∙ Ludwig, M.P. ... Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors Nat. Commun. 2019; 10, 4766 Crossref Scopus (62) PubMed Google Scholar
  58. [77]77. Seyfried, N.T. ∙ Dammer, E.B. ∙ Swarup, V. ... A multi-network approach identifies protein-specific co-expression in asymptomatic and symptomatic Alzheimer’s disease Cell Syst. 2017; 4:60-72.e4 Full Text Full Text (PDF) Scopus (275) PubMed Google Scholar
  59. [78]78. Poulopoulos, A. ∙ Murphy, A.J. ∙ Ozkan, A. ... Subcellular transcriptomes and proteomes of developing axon projections in the cerebral cortex Nature. 2019; 565:356-360 Crossref Scopus (103) PubMed Google Scholar
  60. [79]79. Wang, D. ∙ Eraslan, B. ∙ Wieland, T. ... A deep proteome and transcriptome abundance atlas of 29 healthy human tissues Mol. Syst. Biol. 2019; 15, e8503 Crossref Scopus (418) Google Scholar
  61. [80]80. Mangleburg, C.G. ∙ Wu, T. ∙ Yalamanchili, H.K. ... Integrated analysis of the aging brain transcriptome and proteome in tauopathy Mol. Neurodegener. 2020; 15, 56 Crossref Scopus (18) PubMed Google Scholar
  62. [81]81. Liu, Y. ∙ Beyer, A. ∙ Aebersold, R. On the dependency of cellular protein levels on mRNA abundance Cell. 2016; 165:535-550 Full Text Full Text (PDF) Scopus (1865) PubMed Google Scholar
  63. [82]82. Meissner, F. ∙ Geddes-McAlister, J. ∙ Mann, M. ... The emerging role of mass spectrometry-based proteomics in drug discovery Nat. Rev. Drug Discov. 2022; 21:637-654 Crossref Scopus (122) PubMed Google Scholar
  64. [83]83. Bartel, D.P. MicroRNAs: genomics, biogenesis, mechanism, and function Cell. 2004; 116:281-297 Full Text Full Text (PDF) Scopus (31464) PubMed Google Scholar
  65. [84]84. Vuong, C.K. ∙ Black, D.L. ∙ Zheng, S. The neurogenetics of alternative splicing Nat. Rev. Neurosci. 2016; 17:265-281 Crossref Scopus (224) PubMed Google Scholar
  66. [85]85. Da Cruz, S. ∙ Cleveland, D.W. Understanding the role of TDP-43 and FUS/TLS in ALS and beyond Curr. Opin. Neurobiol. 2011; 21:904-919 Crossref Scopus (285) PubMed Google Scholar
  67. [86]86. Fromer, M. ∙ Roussos, P. ∙ Sieberts, S.K. ... Gene expression elucidates functional impact of polygenic risk for schizophrenia Nat. Neurosci. 2016; 19:1442-1453 Crossref Scopus (711) PubMed Google Scholar
  68. [88]88. Jaffe, A.E. ∙ Straub, R.E. ∙ Shin, J.H. ... Developmental and genetic regulation of the human cortex transcriptome illuminate schizophrenia pathogenesis Nat. Neurosci. 2018; 21:1117-1125 Crossref Scopus (224) PubMed Google Scholar
  69. [89]89. Furlanis, E. ∙ Traunmüller, L. ∙ Fucile, G. ... Landscape of ribosome-engaged transcript isoforms reveals extensive neuronal-cell-class-specific alternative splicing programs Nat. Neurosci. 2019; 22:1709-1717 Crossref Scopus (74) PubMed Google Scholar
  70. [92]92. Toiber, D. ∙ Azkona, G. ∙ Ben-Ari, S. ... Engineering DYRK1A overdosage yields Down syndrome-characteristic cortical splicing aberrations Neurobiol. Dis. 2010; 40:348-359 Crossref Scopus (51) PubMed Google Scholar
  71. [93]93. Vilardell, M. ∙ Rasche, A. ∙ Thormann, A. ... Meta-analysis of heterogeneous Down syndrome data reveals consistent genome-wide dosage effects related to neurological processes BMC Genomics. 2011; 12, 229 Crossref Scopus (95) PubMed Google Scholar
  72. [94]94. Kuhn, D.E. ∙ Martin, M.M. ∙ Feldman, D.S. ... Experimental validation of miRNA targets Methods. 2008; 44:47-54 Crossref Scopus (321) PubMed Google Scholar
  73. [96]96. Muskens, I.S. ∙ Li, S. ∙ Jackson, T. ... The genome-wide impact of trisomy 21 on DNA methylation and its implications for hematopoiesis Nat. Commun. 2021; 12, 821 Crossref Scopus (33) PubMed Google Scholar
  74. [97]97. Zhang, X. ∙ Chen, M.H. ∙ Wu, X. ... Cell-type-specific alternative splicing governs cell fate in the developing cerebral cortex Cell. 2016; 166:1147-1162.e15 Full Text Full Text (PDF) Scopus (222) PubMed Google Scholar
  75. [100]100. Zhang, M. ∙ Ergin, V. ∙ Lin, L. ... Axonogenesis is Coordinated by Neuron-Specific Alternative Splicing Programming and Splicing Regulator PTBP2 Neuron. 2019; 101:690-706.e10 Full Text Full Text (PDF) Scopus (54) PubMed Google Scholar
  76. [101]101. Benavides-Piccione, R. ∙ Ballesteros-Yáñez, I. ∙ de Lagrán, M.M. ... On dendrites in Down syndrome and DS murine models: a spiny way to learn Prog. Neurobiol. 2004; 74:111-126 Crossref Scopus (111) PubMed Google Scholar
  77. [102]102. Cramer, N. ∙ Galdzicki, Z. From abnormal hippocampal synaptic plasticity in Down syndrome mouse models to cognitive disability in Down syndrome Neural Plast. 2012; 2012, 101542 Crossref Scopus (47) PubMed Google Scholar
  78. [103]103. Haas, M.A. ∙ Bell, D. ∙ Slender, A. ... Alterations to dendritic spine morphology, but not dendrite patterning, of cortical projection neurons in Tc1 and Ts1Rhr mouse models of Down syndrome PLoS One. 2013; 8, e78561 Crossref Scopus (38) Google Scholar
  79. [104]104. Engle, E.C. Human genetic disorders of axon guidance Cold Spring Harbor Perspect. Biol. 2010; 2, a001784 Crossref Scopus (161) PubMed Google Scholar
  80. [105]105. Nakai, N. ∙ Takumi, T. ∙ Nakai, J. ... Common defects of spine dynamics and circuit function in neurodevelopmental disorders: A systematic review of findings from in vivo optical imaging of mouse models Front. Neurosci. 2018; 12, 412 Crossref Scopus (36) PubMed Google Scholar
  81. [106]106. Lo, L.H.-Y. ∙ Lai, K.-O. Dysregulation of protein synthesis and dendritic spine morphogenesis in ASD: studies in human pluripotent stem cells Mol. Autism. 2020; 11, 40 Crossref Scopus (23) PubMed Google Scholar
  82. [107]107. Bahn, S. ∙ Mimmack, M. ∙ Ryan, M. ... Neuronal target genes of the neuron-restrictive silencer factor in neurospheres derived from fetuses with Down’s syndrome: a gene expression study Lancet. 2002; 359:310-315 Full Text Full Text (PDF) Scopus (184) PubMed Google Scholar
  83. [108]108. Guo, Y. ∙ Liu, Z. ∙ Chen, Y.K. ... Neurons with multiple axons have functional axon initial segments Neurosci. Bull. 2017; 33:641-652 Crossref Scopus (13) PubMed Google Scholar
  84. [110]110. Cox, J. ∙ Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification Nat. Biotechnol. 2008; 26:1367-1372 Crossref Scopus (10738) PubMed Google Scholar
  85. [111]111. Tyanova, S. ∙ Temu, T. ∙ Cox, J. The MaxQuant computational platform for mass spectrometry-based shotgun proteomics Nat. Protoc. 2016; 11:2301-2319 Crossref Scopus (2786) PubMed Google Scholar
  86. [112]112. Dobin, A. ∙ Davis, C.A. ∙ Schlesinger, F. ... STAR: ultrafast universal RNA-seq aligner Bioinformatics Oxf. Engl. 2013; 29:15-21 Crossref Scopus (26779) PubMed Google Scholar
  87. [113]113. Huang, D.W. ∙ Sherman, B.T. ∙ Lempicki, R.A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists Nucleic Acids Res. 2009; 37:1-13 Crossref Scopus (11188) PubMed Google Scholar
  88. [114]114. Shannon, P. ∙ Markiel, A. ∙ Ozier, O. ... Cytoscape: A software environment for integrated models of biomolecular interaction networks Genome Res. 2003; 13:2498-2504 Crossref Scopus (32316) PubMed Google Scholar
  89. [115]115. Li, B. ∙ Dewey, C.N. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome BMC Bioinformatics. 2011; 12, 323 Crossref Scopus (13883) Google Scholar
  90. [116]116. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads EMBnet.journal. 2011; 17:10-12 Crossref Google Scholar
  91. [117]117. Lu, Y. ∙ Baras, A.S. ∙ Halushka, M.K. miRge 2.0 for comprehensive analysis of microRNA sequencing data BMC Bioinformatics. 2018; 19, 275 Crossref Scopus (52) Google Scholar
  92. [118]118. Kozomara, A. ∙ Birgaoanu, M. ∙ Griffiths-Jones, S. miRBase: from microRNA sequences to function Nucleic Acids Res. 2019; 47:D155-D162 Crossref Scopus (2694) PubMed Google Scholar
  93. [119]119. Robinson, M.D. ∙ McCarthy, D.J. ∙ Smyth, G.K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data Bioinformatics Oxf. Engl. 2010; 26:139-140 Crossref Scopus (26556) PubMed Google Scholar
  94. [120]120. Skene, N.G. ∙ Grant, S.G.N. Identification of vulnerable cell types in major brain disorders using single cell transcriptomes and expression weighted cell type enrichment Front. Neurosci. 2016; 10, 16 Crossref Scopus (168) PubMed Google Scholar
  95. [121]121. Yu, G. ∙ Wang, L. ∙ Han, Y. ... clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS A Journal of Integrative Biology. 2012; 16:284-287 Crossref Scopus (18309) PubMed Google Scholar
  96. [122]122. Gu, Z. ∙ Eils, R. ∙ Schlesner, M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data Bioinformatics. 2016; 32:2847-2849 Crossref Scopus (4724) PubMed Google Scholar
  97. [123]123. Barter, R.L. ∙ Yu, B. Superheat: an R package for creating beautiful and extendable heatmaps for visualizing complex data J. Comput. Graph. Stat. 2018; 27:910-922 Crossref Scopus (124) PubMed Google Scholar
  98. [124]124. Langfelder, P. ∙ Horvath, S. WGCNA: an R package for weighted correlation network analysis BMC Bioinformatics. 2008; 9, 559 Crossref Scopus (14566) PubMed Google Scholar
  99. [125]125. Leng, N. ∙ Dawson, J.A. ∙ Thomson, J.A. ... EBSeq: an empirical Bayes hierarchical model for inference in RNA-seq experiments Bioinformatics. 2013; 29:1035-1043 Crossref Scopus (914) PubMed Google Scholar
  100. [126]126. Lawrence, M. ∙ Gentleman, R. ∙ Carey, V. rtracklayer: an R package for interfacing with genome browsers Bioinformatics Oxf. Engl. 2009; 25:1841-1842 Crossref Scopus (456) PubMed Google Scholar
  101. [127]127. Yin, T. ∙ Cook, D. ∙ Lawrence, M. ggbio: an R package for extending the grammar of graphics for genomic data Genome Biol. 2012; 13, R77 Crossref Scopus (226) PubMed Google Scholar
  102. [128]128. Gel, B. ∙ Serra, E. karyoploteR: an R/Bioconductor package to plot customizable genomes displaying arbitrary data Bioinformatics. 2017; 33:3088-3090 Crossref Scopus (354) PubMed Google Scholar
  103. [129]129. Gel, B. ∙ Díez-Villanueva, A. ∙ Serra, E. ... regioneR: an R/Bioconductor package for the association analysis of genomic regions based on permutation tests Bioinformatics. 2016; 32:289-291 Crossref Scopus (295) PubMed Google Scholar
  104. [130]130. Wiseman, F.K. ∙ Al-Janabi, T. ∙ Hardy, J. ... A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome Nat. Rev. Neurosci. 2015; 16:564-574 Crossref Scopus (373) PubMed Google Scholar
  105. [131]131. Reeves, R.H. ∙ Irving, N.G. ∙ Moran, T.H. ... A mouse model for Down syndrome exhibits learning and behaviour deficits Nat. Genet. 1995; 11:177-184 Crossref Scopus (789) PubMed Google Scholar
  106. [132]132. Reinholdt, L.G. ∙ Ding, Y. ∙ Gilbert, G.J. ... Molecular characterization of the translocation breakpoints in the Down syndrome mouse model Ts65Dn Mamm. Genome. 2011; 22:685-691 Crossref Scopus (146) PubMed Google Scholar
  107. [133]133. Parrini, M. ∙ Naskar, S. ∙ Alberti, M. ... Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome Mol. Ther. 2021; 29:3072-3092 Full Text Full Text (PDF) Scopus (17) PubMed Google Scholar
  108. [134]134. Savardi, A. ∙ Borgogno, M. ∙ Narducci, R. ... Discovery of a small molecule drug candidate for selective NKCC1 inhibition in brain disorders Chem. 2020; 6:2073-2096 Full Text Full Text (PDF) Scopus (46) PubMed Google Scholar
  109. [136]136. Ewels, P. ∙ Magnusson, M. ∙ Lundin, S. ... MultiQC: summarize analysis results for multiple tools and samples in a single report Bioinformatics. 2016; 32:3047-3048 Crossref Scopus (3624) PubMed Google Scholar
  110. [137]137. Yates, A.D. ∙ Achuthan, P. ∙ Akanni, W. ... Ensembl 2020 Nucleic Acids Res. 2020; 48:D682-D688 Crossref Scopus (1119) PubMed Google Scholar
  111. [139]139. Robinson, M.D. ∙ Oshlack, A. A scaling normalization method for differential expression analysis of RNA-seq data Genome Biol. 2010; 11, R25 Crossref Scopus (4948) PubMed Google Scholar
  112. [140]140. Ritchie, M.E. ∙ Phipson, B. ∙ Wu, D. ... limma powers differential expression analyses for RNA-sequencing and microarray studies Nucleic Acids Res. 2015; 43, e47 Crossref Scopus (21508) PubMed Google Scholar
  113. [142]142. Gel, B. ∙ Serra, E. karyoploteR: an R/Bioconductor package to plot customizable genomes displaying arbitrary data Bioinformatics. 2017; 33:3088-3090 Crossref Scopus (354) PubMed Google Scholar
  114. [144]144. Batth, T.S. ∙ Tollenaere, M.X. ∙ Rüther, P. ... Protein Aggregation Capture on Microparticles Enables Multipurpose Proteomics Sample Preparation Mol. Cell. Proteom. 2019; 18:1027-1035 Full Text Full Text (PDF) Scopus (160) PubMed Google Scholar
  115. [146]146. L.P.Bouvrette, B. ∙ Bovaird, S. ∙ Blanchette, M. ... oRNAment: a database of putative RNA binding protein target sites in the transcriptomes of model species Nucl. Acids Res. 2019; 48:D166-D173 Crossref Scopus (56) Google Scholar
  116. [147]147. Grant, C.E. ∙ Bailey, T.L. ∙ Noble, W.S. FIMO: scanning for occurrences of a given motif Bioinformatics. 2011; 27:1017-1018 Crossref Scopus (2522) PubMed Google Scholar
  117. [148]148. Bailey, T.L. ∙ Johnson, J. ∙ Grant, C.E. ... The MEME suite Nucleic Acids Res. 2015; 43:W39-W49 Crossref Scopus (2260) PubMed Google Scholar

Cited by

Sorted by citations

Authors
Rastogi, M., Bartolucci, M., Nanni, M., Aloisio, M., Vozzi, D., Petretto, A., Contestabile, A., & Cancedda, L.
Affiliations
  • Italian Institute of Technology (IT)
  • Istituto Giannina Gaslini (IT)
Corresponding author
  • Contestabile, Andrea
  • Cancedda, Laura
Venue
Neuron
Publisher
Elsevier BV
Published
2024-08
Volume
112
Issue
15
Pages
2503-2523.e10
ISSN
0896-6273 (ISSN-L)
OpenAlex
W4399107398
Cited by
26
References
27
Citations by year
2026: 12 · 2025: 14
FWCI
10.77
Type
journal article
Language
en
Open access
Locations
  • Neuron (publishedVersion)
  • PubMed (publishedVersion)
  • ArTS Archivio della ricerca di Trieste (University of Trieste https://www.units.it/) (submittedVersion)
Funders
European Research Council (725563)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Down syndrome and intellectual disability research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
Down syndrome, gene overexpression, RNA splicing, cytoskeleton, human induced pluripotent stem cells, postmortem brain, microRNA, cognitive disability, therapeutic target
MeSH terms
Multiomics, Animals, Axons, Brain, Down Syndrome, Female, Humans, Male, Neurons, RNA Splicing, MicroRNAs, Proteomics, Mice, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review